Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Voyageur Pharmaceuticals Ltd.
No Price
Closing Price XTSX 29.04.2026:
0,10 CAD
29.04.2026 14:02
Current Prices from Voyageur Pharmaceuticals Ltd.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
TSX-V
VM.V
CAD
29.04.2026 14:02
0,10 CAD
-0,005 CAD
-4,76 %
UTC
VYYRF
USD
28.04.2026 20:00
0,08 USD
0,00 USD
Share Float & Liquidity
Free Float90,93 %
Shares Float162,39 M
Shares Outstanding178,59 M
Company Profile for Voyageur Pharmaceuticals Ltd. Share
Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the pharmaceutical barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.
